17. 委员会 2006 年报告附件 A 根据日本原子弹爆炸幸存者数据，对癌症的发生率和死亡率风险进行了重新评估，并尽可能采用了最新的 DS02 剂量测定法和跟踪调查。附件 A 还全面审查了对由于治疗、诊断和职业原因受到辐射照射的人群进行的各种研究所提供的所有证据。附件 A 审查了患唾腺癌、食管癌、胃癌、小肠（包括十二指肠）癌、结肠癌、直肠癌、肝癌、胰腺癌、肺癌、骨癌和结蒂组织癌、女性乳腺癌、子宫癌、卵巢癌、前列腺癌、膀胱癌、肾癌、脑和中央神经系统癌，以及甲状腺癌的风险；此外还审查了患非霍奇金淋巴瘤、霍奇金病、多发性骨髓瘤、白血病、皮肤黑素瘤和非黑素瘤皮肤癌的风险。这就在一定程度上扩大了委员会 2000 年报告中所审查的器官部位（唾腺癌、小肠癌、直肠癌、胰腺癌、卵巢癌和肾癌，而且该报告也没有审查皮肤黑素瘤）的范围。同委员会 2000 年报告一样，附件 A 分别评估了内部和外部辐射照射以及所谓的低度和高度线性能量传递辐射所带来的风险。
17. Annex A of the Committee’s 2006 report reassesses the risk of incidence and the mortality of cancer from the data on Japanese atomic bombing survivors, wherever possible making use of the latest DS02 dosimetry and follow-up. It also comprehensively reviews all the evidence from studies of groups of people exposed therapeutically, diagnostically and occupationally. Annex A considers risks of cancers of the salivary gland, oesophagus, stomach, small intestine (including duodenum), colon, rectum, liver, pancreas, lung, bone and connective tissue, female breast, uterus, ovary, prostate, urinary bladder, kidney, brain and central nervous system, and thyroid; and risks of non-Hodgkin’s lymphoma, Hodgkin’s disease, multiple myeloma, leukaemia, cutaneous melanoma, and non-melanoma skin cancer. This somewhat extends the list of organ sites from those that had been considered in the Committee’s 2000 report (cancers of the salivary gland, small intestine, rectum, pancreas, uterus, ovary and kidney, and cutaneous melanoma were not considered in that report). As with the Committee’s 2000 report, annex A assesses separately the risks arising from internal and external exposure to radiation, and from so-called low-LET and high-LET (linear energy transfer) radiation.